TUMOR RECURRENCE

Clinical trials for TUMOR RECURRENCE explained in plain language.

Never miss a new study

Get alerted when new TUMOR RECURRENCE trials appear

Sign up with your email to follow new studies for TUMOR RECURRENCE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New Tumor-Injected drug shows promise in early cancer trial

Disease control Recruiting now

This early-stage trial tests a new drug called ONM-501, which is injected directly into tumors, either alone or with the immunotherapy cemiplimab (Libtayo). The study includes 168 adults with advanced solid tumors or lymphomas that have not responded to standard treatments. The m…

Matched conditions: TUMOR RECURRENCE

Phase: PHASE1 • Sponsor: OncoNano Medicine, Inc. • Aim: Disease control

Last updated Jun 27, 2026 08:06 UTC

TUMOR RECURRENCE

Get alerted when new TUMOR RECURRENCE trials appear

New Tumor-Injected drug shows promise in early cancer trial